PRVB
$4.16
Provention Bio
$.76
22.35%
PRVB
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.44)
Revenue:  $0.71 Mil
Thursday
Feb 24
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when PRVB reports earnings?
Beat
Meet
Miss

Where is PRVB's stock price going from here?
Up
Flat
Down
Stock chart of PRVB
Analysts
Summary of analysts' recommendations for PRVB
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Provention Bio, Inc. is a biopharmaceutical company. It focuses on development of novel therapeutics and solutions to intercept and prevent immune-mediated disease. The company's product pipeline consists of PRV-031, PRV-6527, PRV-300, PRV-3279 and PRV-101 which are in clinical stage. Provention Bio, Inc. is based in NJ, United States.